Immun-oncology Models
Direct Cell Killing Assay
Direct cell killing is one of the mechanisms of action of monoclonal antibody therapies, a major development in the immuno-oncology space. The direct cell killing in vitro assay is a predictive tool for test therapeutic and/or antibody mediated cancer cell death. The assay provides precise control over variables such as cell type and test drug or antibody concentration, offering reproducible data for comparison across different conditions.
Available formats
Standard 96-well format.
Alternative format offerings available upon request.
Pilot assay development is available as a standalone service, or as a built in checkpoint for full studies.
